Impact of Measuring Patient-Reported Outcomes in Dermatology Drug Development
Crossref DOI link: https://doi.org/10.1007/s40271-016-0196-6
Published Online: 2016-09-15
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Copley-Merriman, Catherine
Zelt, Susan
Clark, Marci
Gnanasakthy, Ari
Funding for this research was provided by:
GlaxoSmithKline
License valid from 2016-09-15